Skip to content
OpenCapital
Get started

Herbalife HLF Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation

Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation at other companies

USANA Health Sciences logo
USANA Health SciencesUSNA
$4.42M+306%

Other financials

Income statement

See full
Revenue$1.3B+7.8%
Gross profit$1.0B+7.3%
Operating income$138.4M+12.7%
Net income$61.9M+22.8%
EPS (diluted)$0.57+16.3%

Balance sheet

See full
Cash & equivalents$451.2M+37.0%
Total debt$2.2B-9.1%
Total equity-$441.5M+40.0%
Total assets$2.9B+7.1%

Cash flow

See full
Operating cash flow$113.8M+56,800%
CapEx$10.9M-40.4%
Free cash flow$102.9M+669%

Valuation

See full
Market cap$1.24B+51.5%
Enterprise value$2.97B+2.8%
P/E5.2×+2.3×
P/S0.2×+0.1×

Profitability

See full
Gross margin77.8%-0.3pp
Operating margin9.7%+0.9pp
Net margin4.7%-1.0pp
FCF margin7.3%+4.0pp

Returns & leverage

See full
Return on equity219.8%—
Debt / equity10.4×—
Current ratio1.2×+0.3×

Where this comes from

Reported directly by Herbalife in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Herbalife’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Herbalife's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Herbalife's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation?
Herbalife (HLF) reported cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation of $97.7M in Q1 2026.
How has Herbalife's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation changed year-over-year?
Herbalife's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation increased by 212.2% year-over-year, from -$87.1M to $97.7M.